We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Commission has ordered U.S. companies Illumina and Grail to keep their organizations separate and look into alternatives to Illumina’s planned $8 billion acquisition. Read More
Australia’s Therapeutic Goods Administration (TGA) is suing a medical device importer and its executive officers for the alleged unlawful importation of surgical face masks. Read More
The Advanced Medical Technology Association (AdvaMed) has developed a special code of ethics to govern dealings with healthcare professionals in India. Read More
Regeneron has persuaded the U.S. Patent Trial and Appeal Board (PTAB) to revisit a Novartis patent covering a syringe used in eye injections. Read More
Israel-based BrainsGate’s ischemic stroke treatment device will face a vote of the FDA’s Neurological Devices Panel of the Medical Devices Advisory Committee, which will meet on Dec. 10 to decide whether to recommend that the agency approve the company’s premarket application. Read More
The FDA has called on breast implant manufacturers to include a Boxed Warning that the products carry significant risks, among other new labeling requirements aimed at improving transparency for those considering the implants. Read More
The FDA’s Centers for Devices and Radiological Health (CDRH) has released a list of priority guidances it plans to publish during fiscal 2022 — including final guidances on remanufacturing and Unique Device Identification, and several draft guidances on software and cybersecurity. Read More
Australia’s Therapeutic Goods Administration (TGA) plans to require healthcare providers to report medical device adverse events and is inviting public comments on the proposal detailed in a discussion paper. Read More
Devices that use artificial intelligence and machine learning should undergo testing that demonstrates their performance during clinically relevant conditions, the FDA, Health Canada and the UK’s Medicines and Healthcare products Regulatory Agency advised in a joint document on good machine learning practice (GMLP) released yesterday. Read More